← SynDRA
GSK239512
SynDRA canonical compound SYN0037807 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | HRH3 |
| Mechanism of action | histamine receptor antagonist |
All known targets
Mechanisms of action (all sources)
- HRH3 ANTAGONIST
- Histamine H3 receptor antagonist
- histamine receptor antagonist
Cross-references
Synonyms
- Gsk-239512
- GSK-239512A
- GSK-239512
- 1-(6-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YL)OXY)PYRIDIN-3-YL)PYRROLIDIN-2-ONE
- UNII-4I7U5C459M
- CHEMBL3092650
- 4I7U5C459M
- YFRBKEVUUCQYOW-UHFFFAOYSA-N
- SCHEMBL167578
- MolPort-035-776-189
- ZINC3961802
- BDBM50444496
- AKOS025291102
- SB16754
- KS-0000063Q
- AS-42474
- AK171368
- 2-Pyrrolidinone, 1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-3-pyridinyl)-
- J3.497.402K
- RefChem:782734
- MFCD27922168
- orb1305080
- SCHEMBL29360933
- GLXC-07562
- VDB69169
- EX-A12365
- DA-63928
- HY-106000
- CS-0024606
- T27462
- F387863
Look up GSK239512 in the interactive SynDRA portal →